Editor's Note on 'Cancer-derived p53 mutants suppress p53-target gene expression-potential mechanism for gain of function of mutant p53'

被引：0
|
作者：
Sale, Julian E.
Stoddard, Barry L.
机构：
来源：
NUCLEIC ACIDS RESEARCH | 2023年 / 51卷 / 02期
关键词：
D O I：
10.1093/nar/gkac1265
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：997 / 1000
页数：4
相关论文
共 50 条
  • [41] Proteasome inhibitors suppress the protein expression of mutant p53
    Halasi, Marianna
    Pandit, Bulbul
    Gartel, Andrei L.
    CELL CYCLE, 2014, 13 (20) : 3202 - 3206
  • [42] Modulation of gene expression by tumor-derived p53 mutants
    Scian, MJ
    Stagliano, KER
    Ellis, MA
    Hassan, S
    Bowman, M
    Miles, MF
    Deb, SP
    Deb, S
    CANCER RESEARCH, 2004, 64 (20) : 7447 - 7454
  • [43] A Chimeric p53 Evades Mutant p53 Transdominant Inhibition in Cancer Cells
    Okal, Abood
    Mossalam, Mohanad
    Matissek, Karina J.
    Dixon, Andrew S.
    Moos, Philip J.
    Lim, Carol S.
    MOLECULAR PHARMACEUTICS, 2013, 10 (10) : 3922 - 3933
  • [44] HETEROGENEITY OF TRANSCRIPTIONAL ACTIVITY OF MUTANT P53 PROTEINS AND P53 DNA TARGET SEQUENCES
    CHEN, JY
    FUNK, WD
    WRIGHT, WE
    SHAY, JW
    MINNA, JD
    ONCOGENE, 1993, 8 (08) : 2159 - 2166
  • [45] The transcription and expression profile of p53N236S mutant reveals new aspects of gain of function for mutant p53
    Wang, Boyuan
    Dan, Juhua
    Li, Haili
    Hou, Jing
    Shi, Mingling
    Sanjay, Kumar Singh
    Chang, Jeffrey T.
    Luo, Ying
    FEBS LETTERS, 2018, 592 (18): : 3183 - 3197
  • [46] Mutant p53 in colon cancer
    Nakayama, Mizuho
    Oshima, Masanobu
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (04) : 267 - 276
  • [47] Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
    Schulz-Heddergott, Ramona
    Moll, Ute M.
    CANCERS, 2018, 10 (06)
  • [48] Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
    Michael J. Duffy
    Naoise C. Synnott
    John Crown
    Breast Cancer Research and Treatment, 2018, 170 : 213 - 219
  • [49] Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
    Duffy, Michael J.
    Synnott, Naoise C.
    Crown, John
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (02) : 213 - 219
  • [50] Target p53 functionally null ovarian cancers for p53 gene replacement: Not all p53 mutations are created equal!
    Buller, RE
    Shahin, MS
    Hughes, JH
    Sorosky, JI
    Anderson, B
    Sood, AK
    CANCER GENE THERAPY, 1999, 6 (06) : S4 - S4
12345